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Background: The annual global neonatal mortality stands at 2.5 million deaths, 1 million of
them dying within the first day of life. An additional 2.6 million are stillborn globally, the
majority of them due to intrapartum events. Optimal fetal heart rate (FHR) monitoring has
the potential to timely detect fetuses at risk and, if coupled with timely obstetric responses
may save more newborns. Moyo is a new Doppler with nine crystals capable of monitoring
FHR both intermittently and continuously.
Aim: To assess women’s and midwives’ opinions on the use of Moyo for intrapartum FHR
monitoring.
Methods: We conducted a cross-sectional study using a structured questionnaire to assess
women’s and midwives’ perception. Women who gave birth at the hospital who used Moyo
were interviewed using a questionnaire immediately before discharge from the hospital.
Twenty-eight midwives who have been using Moyo for more than 6 months were also
interviewed using a structured questionnaire. Data were analyzed using excel and result
presented in figures.
Results: In total 113 postpartum women who were monitored using Moyo were interviewed
before discharge. Out of these, 46 (40.7%) were first-time mothers and the rest were multipara.
In total, 95 women (84.1%) used Moyo and other devices for FHR monitoring, 81 (72%) said
Moyo was better than Fetoscopes and handheld Doppler, two-third 75 (66.4%) felt that Moyo
was comfortable and 93 (82.3%) would like Moyo to be used on them in the future. Out of 28
midwives, 11 (39.3%) used Moyo continuous only, 3 (10.7%) used Moyo intermittently only
and 14 (50.0%) used both intermittent and continuous. Thirteen (46.4%) midwives prefer to
use Moyo both intermittent and continuous. Sixteen (55.6%) said Moyo was effective, 21
(75%) felt comfortable to use Moyo, and 13 (46.4%) said Moyo was easy to use.
Conclusion: The majority of midwives and women who used Moyo felt that Moyo was
comfortable for intrapartum FHR monitoring. Moyo can be used both intermittently and
continuously depending on the user’s preferences.
Keywords: Moyo, fetal heart rate, labor, midwives, women
Introduction
Intrapartum Fetal heart rate (FHR) monitoring intends to assess the well-being of
the fetus and the FHR response to labor for timely obstetric responses.1 Optimal
FHR monitoring coupled with timely obstetric responses is key to ensured good
perinatal outcome.2,3 Globally, there are about 2.5 million neonatal deaths and
2.6 million stillborn annually. Almost half of the stillborn are alive at the start of
labor. Likewise, 44% of the neonatal deaths occur on the first day of life and are the
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results of intrapartum events.4,5 Events during labor
including birth asphyxia account for one-quarter of the
global newborn deaths.6 More than half of newborns
deaths of term babies with normal birth weight in a rural
hospital in Tanzania found to be associated with birth
asphyxia.7
In the resource-limited settings with high neonatal mor-
tality rates, FHR monitoring is mainly performed intermit-
tently using Pinard Fetoscope.8 However, recently, Doppler
has been tested for intermittent FHR monitoring in several
parts of low-resource setting showing evidence of effective-
ness in detecting abnormal FHR.9–11 The wind-up hand-held
Doppler use among women seems to be more preferred by
laboring women as compared to fetoscope.12
Moyo is a novel strap-on FHR monitor equipped with
a rechargeable battery (Figure 1). When fully charged, the
battery can last for more than 10 hrs while being used for
continuous monitoring. Moyo monitor contains nine-crystal
Doppler ultrasound sensors which facilitate the rapid identi-
fication of FHR (within 5 s) and has a wide detection area
(15 cm radius)' hence eliminates the necessity of palpating the
area of high FHR intensity as is for Fetoscope and ordinary
Doppler. It is designed for both intermittent auscultation and
continuous monitoring. In a situation where it is uncertain
whether the detected heart rate is fetal or maternal, Moyo has
two dry-electrode electrocardiograms for the mother to place
her fingers. Both the maternal and fetal pulse rates are then
simultaneously displayed. The inbuilt alarm function will
alert the midwives in case of persistent (>3 mins) abnormal
FHR when used in continuous mode.13,14
Moyo has been in use since 2015 both in rural and
urban Tanzania13,14 but the users’ opinions (both women
and midwives) are less explored. The present study
assessed the midwives’ and women’s opinions on the
intrapartum use of Moyo for FHR monitoring.
Methods
Study Setting
The study was conducted at Haydom Lutheran hospital
which is a referral hospital located in rural Northern
Figure 1 Moyo fetal heart rate monitor.
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Tanzania, 300 km from the nearest urban center with a well-
established infrastructure for collaborative research and data
collection. It is the referral hospital for approximately
500,000 people, while the greater reference area covers
about two million people. The hospital has about 4500
deliveries per year with a cesarean section rate of 21%.
Intrapartum FHR monitoring was mainly performed inter-
mittently using a fetoscope and handheld Doppler until 2015
when Moyo was introduced into clinical use. The intrapar-
tum care is mainly done by midwives who are responsible
for managing normal pregnancy, labor, and delivery. Intern
Doctors in consultation with obstetricians are responsible for
supporting midwives during difficult deliveries including
performing a cesarean section. All midwives and doctors
were trained on the use of both fetoscopes, free play hand-
held Doppler and Moyo. All these devices were used for
intrapartum FHR monitoring in the labor ward for at least
1 year prior to the study. Midwives had a choice which
device to use for FHR monitoring.
Study Design and Data Collection
This is a cross-section survey conducted at Haydom
Lutheran Hospital maternity ward between July and
September 2017. The pretested structured questionnaire
was used to interview women post-delivery before dis-
charge. The main focus of the questionnaire was the
women’s experience of Moyo used on them during labor.
The questionnaire included questions regarding preference
and if a woman prefers Moyo or other devices. Women
were asked to grade the Moyo comfortability as: (1) Very
comfortable, (2) Comfortable, (3) Not comfortable, (4)
Very uncomfortable. Comparing with other devices,
women who ever used other devices were asked to grade
Moyo in comparison with previously used devices as: (1)
Previous device was better than Moyo; (2) They are the
same; (3) Moyo is better than the previous one. Women
were asked if they would like Moyo to be used on them
next time. They answered the question by grading as: (1)
Not at all; (2) Not sure; (3) I want Moyo to be used on me;
(4) I would prefer another device if available.
Midwives were interviewed using the structured ques-
tionnaire regarding their opinions on using Moyo as com-
pared to other fetal heart monitoring devices used in the
setting. The focus was to assess the easiness of use, com-
fortability of use and perceived effectiveness.
The research nurses interviewed women using the
questionnaires at their convenient time using the language
of their choice. The midwives were given a self-
administered questionnaire in the Swahili language and
asked to fill the questionnaire.
Sample Size Estimations and Data
Analysis
We employed a convenient sampling technique, where post-
partum women whom Moyo used to monitor fetal heart rate
during the study period were recruited. Women with
a negative labor outcome were excluded from the study.
The maternity ward had 36 midwives during the study
period, 30 of them involved in labor-management and
therefore have used Moyo and other fetal heart rate mon-
itoring devices at the hospital. Twenty-eight of them who
had worked in the labor ward for at least 6 months at
recruitment, were approached and consented and com-
pleted the questionnaire. Data analysis was performed
using Excel, bar graphs were used to present results.
Ethical Considerations
The permission to conduct the study was granted by the
hospital authority and Tanzania National Institute for
Medical Research (NIMR) ethical committee.
Researchers were trained on confidentiality and signed
a confidentiality agreement to ensure the confidentiality
during the data collection. The hospital and the National
ethical committee (NIMR) approved the use of verbal
consent which was obtained from all women and mid-
wives before filling the questionnaires.
Results
During the study, 141 midwives and women participated
in the study, 28 midwives (24 females and 4 Males), and
113 postpartum women.
The age of midwives filled the questionnaires were in
the range of 21–50 years, all of them had used Moyo for
monitoring FHR either intermittently (14/28), or continu-
ous only (11/28) or both (14/28). The average years of
working as midwife was 3.6 years.
More than 70% of midwives thought that Moyo was
either very easy or easy to use for intrapartum FHR mon-
itoring. Almost 90% and more than half of the midwives
thought that Moyo was comfortable to use and effective
for intrapartum FHR monitoring, respectively, Figure 2.
The age of women interviewed were in the range of
19–44 years, two-fifth of them being first-time mothers at
the time of interview. More than 90% of women inter-
viewed admitted that the device was comfortable with
Dovepress Mdoe et al
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them. More than 70% of the interviewed women who have
ever used other devices admitted that Moyo was better
than the other ever used devices for intrapartum FHR
monitoring, Figure 3.
Discussion
Fetal heart rate monitoring during labor is the most and
necessary part of labor management. Devices commonly
used to monitor intrapartum FHR were fetoscope and
single-crystal Doppler which were used intermittently.
Moyo is the multi-crystal Doppler capable of monitoring
FHR both intermittently and continuously. It was recently
introduced for FHR monitoring, for most midwives Moyo
was new and used for the first time at Haydom Lutheran
Hospital. Likewise, it was new to most women who gave
birth at Haydom even among the multipara’s women.
The present study reports that both midwives and
women liked Moyo and thought it was much more com-
fortable in monitoring FHR. The findings concur with
Mangesi L et al 2009 findings, that women and midwives
were comfortable using Doppler as compared to
fetoscope.12 Likewise, the two studies conducted by Sara
et 2018 and 2019 report similar findings that women felt
that Moyo was good on them and they were more comfor-
table likewise, the midwives liked using Moyo.15,16
Midwives and mothers seem to adapt Moyo easily, about
90% of midwives were comfortable using Moyo and 66.4%
of women said were comfortable when Moyo used on them.
This may mean that they both understand how it works and
they are satisfied with the technology. Additionally, this is
a good indication that Moyo can easily be adapted by mid-
wives working in the low setting areas as was targeted. The
midwives’ positive perception of Moyo may have influenced
their usage and trust on the device hence facilitate the proper
utilization of the device. Likewise, women on whom Moyo
used, they liked it which may have facilitated good commu-
nication and interaction between laboring women and the
attending midwife.
The pre and post-implementation study using Moyo in
one of the urban hospitals showed that the level of partogram
documentation improved during the Moyo use as compared
to before Moyo.17 In the same setting midwives and women
had a strong positive perception towards Moyo in-terms of
comfortability and effectiveness.15,16 Our findings are similar
to these studies conducted in the urban hospitals. The result
of this present study should be translated into improved FHR
monitoring practices including timely responses.
The strength of the study: The measure of both provi-
ders and women who received services gave strength to
the study. Likewise, interviewing women shortly before
Figure 2 Midwives opinions on using Moyo for intrapartum FHR monitoring.
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discharge gave them more freedom to share their opinions
thus reduced the chance of biased information.
Limitations
The study had several limitations including a single-site
study, not including women with unpleasant labour out-
comes. Use of questionnaire limit women and midwives to
give details or explain themselves about the equipment
thus in-depth interview could be more appropriate.
Conclusion
Intrapartum fetal heart monitoring usingMoyo perceived posi-
tively by both midwives and women. The majority of women
andmidwives who usedMoyo felt thatMoyowas comfortable
for intrapartum FHR monitoring. Moyo can be used both
intermittently and continuously depending on the user’s
preferences.
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Figure 3 Women’s opinions on Moyo compared with other FHR monitoring devices ever used on them.
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